Latest Breaking News On - Benjamin kreitman - Page 1 : comparemela.com

IsomAb secures funds to advance peripheral arterial disease treatment

IsomAb has secured £7.5m in a seed funding round to expedite the development of its lead candidate targeting peripheral arterial disease.

Jackie turnbullBenjamin kreitmanEuropean regional development fundEuropean unionUniversity of nottinghamProof of concept early stage fundInvestment funds growth programmeMidlands engine investment fundEuropean investment bankBroadview venturesEarly stageEarly stage fundEuropean structuralEuropean investment

IsomAb builds towards £35m Series A after £7 5m seed round is backed by US money

Biotech company IsomAb Ltd, whose registered office is at St John’s Innovation Centre in Cambridge, has excited investors with its antibody technology. The company has closed a £7.5 million financing to accelerate its lead candidate to treat peripheral arterial disease.

United kingdomUnited statesHannah tapsell chapmanHarry destecroixDavid batesJackie turnbullBenjamin kreitmanProof of concept early stage fundExonate ltdPrincipal at broadview ventures incBusiness weeklyBroadview venturesEarly stage fundChief scientific officer dr david batesChief scientific officerScientific advisory

IsomAb Announces Close of £7 5 Million Financing to Accelerate Lead Candidate for Treatment of Peripheral Arterial Disease

/PRNewswire/ IsomAb Ltd, a UK-based biotechnology company, announced today the closing of a £7.5 million (approximately US$9.4 million) Seed financing.

City ofUnited kingdomHarry destecroixJackie turnbullHannah tapsell chapmanBenjamin kreitmanProof of concept early stage fundHuman healthPrnewswire isomab ltdUniversity of nottinghamResearch councilUniversity of bristolEuropean unionEuropean regional development fundMidlands engine investment fundInvestment funds growth programme

HAYA Therapeutics Completes CHF 18 Million Seed Financing To Advance Anti-fibrotic Therapies Targeting Long Non-coding RNAs

HAYA Therapeutics Completes CHF 18 Million Seed Financing To Advance Anti-fibrotic Therapies Targeting Long Non-coding RNAs
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSwitzerland generalRobert williamsonBenjamin kreitmanViva bioinnovatorSchroder adveqJens ecksteinSamir ounzainLausanne university hospitalBiotheryx incApollo health venturesPartner at apollo health venturesBroadview venturesExecutive chairManaging partnerDaniel blessing